Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Negative Symptoms and Cognition Impairment of Schizophrenia Patients

NCT04521868 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT04521868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04521868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Negative Symptoms and Cognition Impairment of Schizophrenia Patients
Lead sponsor
Central South University
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2020
Completion date
August 12, 2022
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia